The present study was conducted to explore the source of acetylcholine (ACH) in the corpus luteum (CL) and to test our hypothesis of an antiapoptotic role of ACH in the bovine CL and, further, to investigate whether nerve growth factor (NGF), insulin-like growth factor 1 (IGF1), and transforming growth factor beta1 (TGFB1) influence the expression of choline acetyltransferase (CHAT), the biosynthetic enzyme of ACH, in cultured bovine luteal cells. Protein expression and immunolocalization of CHAT were carried out at different stages throughout the luteal phase and in cultured luteal and endothelial cells. ACH was measured in luteal tissue at the different luteal stages and in luteal cells cultured for 8 and 24 h. Cell viability and TUNEL assays were performed on cultured midluteal cells treated with or without tumor necrosis factor alpha (TNF)/interferon gamma (IFNG) in the presence of ACH and its muscarinic (atropine) and nicotinic (mecamylamine) receptor antagonists. The CL was devoid of cholinergic nerve fibers. CHAT immunostaining was evident in luteal, endothelial, and stromal cells in luteal tissue sections and in cultured luteal and endothelial cells. CHAT protein was expressed throughout the cycle without any significant changes. ACH concentration in luteal tissue was not changed during the luteal stages but increased over time and with increased cell numbers in luteal cell cultures. ACH increased cell viability and prevented cell death induced by TNF/IFNG. Atropine significantly attenuated ACH action, whereas mecamylamine had no effect. TNF/IFNG treatment downregulated CHAT expression, whereas NGF, IGF1, and TGFB1 upregulated CHAT expression, in cultured luteal cells. The overall findings strongly suggest a nonneural source and antiapoptotic role of ACH in the bovine CL. Locally produced ACH appears to be regulated by NGF, IGF1, and TGFB1.
INTRODUCTION
The life span and function of the corpus luteum (CL) are regulated by luteotrophic and luteolytic hormones, growth factors, cytokines, and neurotransmitters [1] [2] [3] . Neurotransmitters likely play a special role in the neuron-endocrinotrophic stimulatory complex in the ovary [4] . A better understanding about the role of neurotransmitters in the CL is physiologically important and can advance our current knowledge regarding the regulatory mechanism of CL function. Acetylcholine (ACH) stimulates the production of progesterone (P 4 ) and oxytocin in cultured bovine luteinized granulosa cells [3] as well as P 4 and estrogen in cultured human granulosa cells [5] . Moreover, ACH has a modulatory effect on gonadotropinstimulated steroid production by luteinized human granulosa cells [6] . Despite those facts, little information is available concerning the source and other possible roles of ACH in the CL.
The ovary is assumed to be devoid of cholinergic innervation fibers [7, 8] . De novo synthesis and ACH release have been demonstrated in the granulosa cells of healthy follicles in primates, humans, and rats [8] [9] [10] [11] . A nonneural source of ACH has been demonstrated in various cell types in the body, such as syncytiotrophoblast and amnion epithelial cells in the placenta [12, 13] ; spermatogenic cells in the testis [14] ; gastrointestinal, respiratory, and urogenital epithelial cells [15] [16] [17] ; and immune cells, including lymphocytes [18] , mucocutaneous epithelial cells and keratinocytes [19] , and vascular endothelial cells [20] . ACH seems to serve as a local mediator, regulating various physiological functions, including mitosis, differentiation, cell-to-cell contact, secretion, and immune functions in nonneural tissues [15, 16] .
Acetylcholine is synthesized from choline and acetyl coenzyme A by the enzyme choline acetyltransferase (CHAT) in cholinergic nerve terminals, translocated into synaptic vesicles by the vesicular ACH transporter choline (VACHT; official symbol SLC18A3), and then released to interact with cholinergic receptors [12, 21] . ACH action is mediated by two classes of receptors: muscarinic receptors (mACHRs; official symbol CHRM), which contain five subtypes (M 1 -M 5 ), and nicotinic receptors (nACHRs; official symbol CHRN), which consist of two subtypes (alpha and beta), in both neural and nonneural tissues [21] . Several lines of evidence indicate the importance of transforming growth factor (TGF) family members, particularly nerve growth factor (NGF), in the regulatory mechanism of parasympathetic neurons [22] [23] [24] . NGF regulates the expression and activity of CHAT in cholinergic neurons [22] [23] [24] . NGF and both of its receptors, p75 NGFR and the high-affinity TrkA tyrosine kinase receptor (official symbol NTRK1), have been demonstrated in the luteal cells of hamsters [25] . Neonatal immunoneutralization of NGF blocks the development of ovarian innervation and delays follicular growth [26] , suggesting important role of NGF in the ovarian innervation.
The apparent lack of an endogenous source for ACH in the CL is puzzling in respect to reports suggesting a physiological role of ACH in P 4 production [3, 5] . Whether the ovary receives cholinergic innervation fibers is controversial. To our knowledge, the expression of the ACH-synthesizing enzyme CHAT has not been reported in the CL of any species. In the present study, we examined the expression of CHAT as well as the ACH concentration in bovine luteal tissue, tested our hypothesis of an antiapoptotic role for ACH in cultured bovine luteal cells, and determined the type of ACH receptors mediating its antiapoptotic role. We also investigated whether NGF, insulin-like growth factor 1 (IGF1), and transforming growth factor b1 (TGFB1) influence the protein expression of CHAT in cultured bovine midluteal cells.
MATERIALS AND METHODS

Collection of Bovine CL
Bovine CLs were collected from Holstein cows at a local slaughterhouse within 10-20 min after exsanguination. The stage of the estrous cycle was defined as described previously [27] . CLs were classified as early (Days 2-3 after ovulation, n ¼ 4), developing (Days 5-6, n ¼ 4), mid (Days 8-12, n ¼ 4), late (Days 15-17, n ¼ 4), and regressed (Days 19-21, n ¼ 4) luteal stages. After determination of these stages, CLs were immediately separated from the ovaries, frozen rapidly in liquid nitrogen, and then stored at À808C until processing for protein expression. For immunohistochemistry, pieces of CLs were fixed in 10% (v/v) neutral formalin (pH 7.4) for 20-24 h and then embedded in paraffin. For cell culture, ovaries with midluteal CLs were submerged in ice-cold physiological saline and transported to the laboratory.
Immunohistochemistry
Sections (thickness, 6 lm) were mounted on glass slides precoated with silane (S3003; DAKO) and dried for 3 h at 608C. Sections were deparaffined, rehydrated, and washed in tap water for 10 min, followed by immersion in methanol with 0.3% (v/v) H 2 O 2 for 30 min. No antigen retrieval was required according to the method described by Ratcliffe et al. [28] . After three washes with PBS, sections were incubated with 10% normal rabbit serum (R9133; Sigma) containing 1% (w/v) bovine serum albumin (BSA; A7979; Sigma) diluted in PBS to block nonspecific protein binding. The sections were incubated with goat polyclonal anti-CHAT antibody (AB144P; Chemicon) diluted 1:500 with PBS containing 1% (w/v) BSA overnight at 48C, whereas negative-control sections were incubated with PBS. Subsequently, the sections were washed with PBS three times and incubated with biotinylated anti-goat immunoglobulin (Ig) G (1:200; BA-5000; Vector Laboratories) for 30 min, followed by three washes in PBS and then incubation for 30 min at room temperature with VectaStain avidin-biotin-peroxidase complex (PK6100; Vector Laboratories) according to the manufacturer's instructions. The sections were washed three times and visualized with 0.05% (w/v) 3,3 0 -diaminobenzidine (7411-49-6; Dojindo) in 0.01 M PBS (pH 7.4) and 0.01% (v/v) H 2 O 2 . The sections were washed well with distilled water, counterstained with hematoxylin, dehydrated, mounted with DPX, and then examined with a light microscope. Cultured luteal cells (12-h culture) on coverslips were fixed with 4% paraformaldehyde at 48C for 10 min, followed by three washes in PBS, and then were immunostained as described for paraffin sections.
Protein Detection by Western Blot
The CL tissues and cultured luteal cells were homogenized on ice in homogenization buffer (25 mM Tris-HCl, 300 mM sucrose, and 2 mM ethylenediaminetetra-acetic acid) and Complete (protease inhibitor cocktail; 1697498, pH 7.4; Roche Diagnostics GmbH) by a tissue homogenizer (NS-50; Physcotron; Niti-on, Inc.), then frozen in liquid nitrogen and stored at À808C. For CHAT protein, cytoplasm was isolated from the tissue homogenates by centrifugation at 600 3 g for 30 min. Protein concentration was determined by the method described by Osnes et al. [29] , using BSA as a standard. The proteins were then solubilized in SDS gel-loading buffer (50 mM Tris-HCl, 2% SDS [31607-94; Nacalai Tesque], 10% glycerol, 1% b-mercaptoethanol [137-06862; Wako Pure Chemical Industries Ltd.], pH 6.8) and heated at 958C for 10 min. Samples (50 lg of protein) were subjected to electrophoresis on a 17% SDS-PAGE for 1.5 h at 200 V. The separated proteins were electrophoretically transblotted to a 0.2-lm nitrocellulose membrane (LC2000; Invitrogen) at 100 V for 2 h in transfer buffer (25 mM Tris-HCl, 192 mM glycine, and 20% methanol; pH 8.3). The membrane was then washed in TBS-T (0.1% Tween 20 in TBS [25 mM Tris-HCl and 137 mM NaCl]; pH 7.5) and incubated in blocking buffer (4% skim milk in TBS-T) overnight at 48C. After the blocking incubation, the membranes was incubated with goat polyclonal anti-CHAT antibody (AB144P; Chemicon) diluted 1:1000 in TBS-T for 1 h at room temperature and with b-actin (ACTB) antibody (A2228; Sigma) diluted 1:1000 in TBS-T at room temperature. After incubation, the membranes was washed three times for 10 min each time in TBS at room temperature and then incubated with anti-goat IgG and horseradish peroxidase (HRP; 1:20 000) in TBS-T (PI-9500; Vector Laboratories) for CHAT and with sheep anti-mouse IgG and HRP (NA931; Amersham Biosciences) for 1.5 h for ACTB and then washed three times in TBS for 10 min each time at room temperature. The signal was detected by the ECL Western Blotting Detection System (RPN2109; Amersham Biosciences). The intensity of the immunological reaction in the samples was estimated by measuring the optical density in the defined area by computerized densitometry using NIH Image (National Institutes of Health).
Luteal Cell Culture
Only those CLs classified as being in the midluteal stage were collected for the cell culture. Luteal tissue was enzymatically dissociated, and luteal cells were cultured as described previously [30] . The luteal cells were suspended in a culture medium, Dulbecco modified Eagle medium and Ham F-12 medium (D/F; 1:1 [v/v]; D8900; Sigma), containing 5% calf serum (16170-078; Life Technologies) and 20 mg/ml of gentamicin (G1397; Sigma). Cell viability was greater than 85% as assessed by trypan blue exclusion. The cells in the cell suspension consisted of approximately 70% small luteal cells, 20% large luteal cells, 10% endothelial cells or fibrocytes, and no erythrocytes.
Endothelial Cell Culture
Luteal endothelial cells were isolated from developing CL (days 5-8 of the estrous cycle) using enzymatic digestion and magnetic beads (Dynabead M-450; Dynal ASA) coated with lactin BS-1 (2380; Sigma) as described previously [31] . Freshly isolated endothelial cells and endothelial cells at passage 5 were cultured in D/F (1:1 v/v) medium containing 10% calf serum on coverslips in six-well microplates (657-160; Greiner Bio-One GmbH) for 4 days. Coverslips were then washed with PBS three times and fixed with 4% paraformaldehyde at 48C for 10 min, followed by three washes in PBS and then immunostaining as described for paraffin sections.
Experiment 1: Effect of ACH on P 4 Production and Luteal Cell Viability
Dispersed luteal cells were cultured at 2.0 3 10 5 viable cells in 100 ll of D/ F medium containing 5% calf serum in 96-well plates (677-180; Greiner BioOne GmbH). After 12 h of culture, the medium was replaced with fresh medium containing 0.1% BSA, 5 ng/ml of sodium selenite, and 5 lg/ml of transferrin. Preliminary experiments were carried out to determine the concentration of ACH. Cultured luteal cells were treated with ACH chloride (A2661; Sigma) in a dose-dependent manner (10 À9 , 8 3 10 À8 , 5 3 10 À8 , 10 À8 , 10 À7 , 10 À6 , 8 3 10 À5 , 5 3 10 À5 , and 10 À5 M) with or without 2.9 nM TNF (kindly donated by Dainippon Pharmaceutical Co., Ltd.) and 2.5 nM interferon gamma (IFNG; kindly donated by Dr. S. Inumaru) to induce apoptosis. After 24 h, cell viability was determined by WST-1 assay. The P 4 concentrations in the media of luteal cells cultured with ACH were measured by enzyme immunoassay (EIA).
Experiment 2: Effect of ACH Receptor Antagonists on ACH-Induced P 4 Production and Cell Viability
To identify ACH receptors mediating its antiapoptotic role, cultured luteal cells in 96-well plates were treated with ACH chloride (10 À7 M based on experiment 1) in the presence of CHRM antagonist (atropine phosphate; A0257; Sigma), CHRN antagonist (mecamylamine; M9020; Sigma), or a combination of both atropine and mecamylamine in the absence or presence of 2.9 nM TNF and 2.5 nM IFNG. Receptor antagonist concentrations were equivalent to ACH concentration (10 À7 M) based on our preliminary experiments and previous findings [3] . After 24 h of culture, cell viability was determined by WST-1 assay, and apoptotic cells were detected by TUNEL assay on coverslips. The P 4 concentrations in the media of luteal cells cultured with ACH and/or atropine were measured by EIA.
Experiment 3: Effect of TNF/IFNG on CHAT Protein Expression in Cultured Luteal Cells
Dispersed luteal cells were cultured at 2 3 10 5 viable cells in 100 ll of D/F medium containing 5% calf serum in plastic flasks (658-170; Greiner Bio-One GmbH) for Western blotting or on coverslips in six-well microplates for immunocytochemistry. After 12 h of culture, the medium was replaced with fresh medium containing 0.1% BSA, 5 ng/ml of sodium selenite, and 5 lg/ml of transferrin. Cultured midluteal cells were treated with 2.9 nM TNF and 2.5 nM IFNG to induce apoptosis. After 24 h of culture, the total protein was prepared for CHAT immunoblotting, and coverslips were used for immunohistochemistry as described above. 
Experiment 4: Effect of TGF, IGF1, and NGF on CHAT Expression in Cultured Luteal Cells
Cultured midluteal cells in plastic flasks were treated with 100 ng/ml of NGF extracted from murine submaxillary gland (N6009; Sigma), 100 ng/ml of human recombinant TGF (T7039; Sigma), and 100 ng/ml of human recombinant IGF1 (I3769; Sigma). After 24 h of culture, the total protein was prepared for CHAT immunoblotting.
Determination of P 4
Concentrations of P 4 were determined directly from the cell culture media with an EIA as described previously [32] . The standard curve ranged from 0.391 to 100 ng/ml, and the effective dose of the assay for 50% inhibition (ED 50 ) was 4.5 ng/ml. The intra-and interassay coefficients of variation were 6.3% and 10.6%, respectively.
WST-1 Assay
A derivative of MTT [3-(4,5-dimethyl-2 thiazolyl)-2,5-diphenyl-2H-tetrazolium/Br], WST-1 is a yellow tetrazolium salt that is reduced to formazan by live cells containing active mitochondria. For the viability assay, the culture medium was replaced with 100 ll of D/F medium without phenol red, and 10 ll of assay solution (0.3% WST-1 and 0.2 mM 1-methoxy-5-methylphenazinium methylsulfate in PBS; pH 7.4) were added to each well. The cells were then incubated for 4 h at 378C. The absorbance (A) was read at 450 nm using a microplate reader (Model 450; Bio-Rad). Cell viability (%) was calculated as cell viability ð%Þ ¼ 100 3ðA test =A control Þ;
where A control is the mean A of nontreated wells and A test is the mean A of all experimental wells.
ACH Concentration in Luteal Tissues and Cultured Luteal Cells
The CL tissues (15-50 mg) were obtained from the CL of the developing, mid, or late stage. Dispersed luteal cells of the midluteal stage were prepared as stated before and were cultured at 10 5 or 2 3 10 5 viable cells in 100 ll of D/F medium containing 5% calf serum in plastic flasks (658-170; Greiner Bio-One GmbH). After 12 h of culture, the medium was replaced with fresh medium containing 0.1% BSA, 5 ng/ml of sodium selenite, and 5 lg/ml of transferrin. The cells were collected after further culturing for 8 or 24 h. Both luteal cells and tissues were homogenized on ice in 200 ll of homogenization buffer by a tissue homogenizer (NS-50; Physcotron; Niti-on, Inc.). Cytoplasm was isolated from the tissue homogenates by centrifugation at 600 3 g for 30 min. ACH concentrations were measured using a commercially available Choline/ Acetylcholine Quantification Kit (K615-100; BioVision) according to the manufacturer's instructions.
TUNEL Immunofluorescence
Cultured luteal cells on coverslips were treated as mentioned in Experiment 2. After 24 h of culture, coverslips were washed three times in PBS and then fixed with 4% paraformaldehyde at 48C for 10 min, followed by three washes in PBS. Apoptotic cells were detected with MEBSTAIN Apoptosis Kit Direct (8445; MBL International Corporation) according to the manufacturer's instructions. Briefly, coverslips were incubated with terminal deoxynucleotidyl transferase (TdT) buffer II for 5-10 min at room temperature and then incubated with a mixture of 45 ll of TdT buffer II, 2.5 ll of fluorescein isothiocyanate-deoxyuridine triphosphate, and 2.5 ll of TdT for 60 min at 378C, followed by immersion in TB buffer for 15 min and three washes in PBS. After three washes, they were mounted with the Vectashield mounting medium 4 0 ,6 0 -diamidino-2-phenylindole (Tris-like) (H-1500; Vector Laboratories) on slide glass and examined using a fluorescence microscope. The number of positive cells for TUNEL was counted in 20 random microscopic fields. The 
Statistical Analysis
Statistical significance of differences in protein expression or percentage of cells in culture between control and treated groups was assessed by ANOVA, followed by the Fisher protected-least-significant-difference (PLSD) procedure as a multiple-comparison test. All experimental data are shown as the mean 6 SEM. Differences in cell viability were statistically analyzed as relative ratio of the control (untreated cells).
RESULTS
Immunohistochemistry in Luteal Tissues and Cultured Luteal and Endothelial Cells
Luteal tissues appeared to be devoid of cholinergic nerve fibers. Defused immunostaining of CHAT, however, was found predominantly in the stromal cells in the connective tissue (trabeculae regions), in the endothelial cells in large and small blood vessels, and in the luteal cells. No immunostaining was observed in negative-control sections (Fig. 1A) , whereas neural cell bodies in the mouse brain (positive control) were immunostained (Fig. 1B) . Defused immunostaining was seen in the endothelial and luteal cells during the early (Fig. 1C) , developing (Fig. 1D), and mid (Fig. 1E ) luteal stages. Very few luteal cells showed immunostaining during the late (Fig. 1F) and regressed (Fig. 1G) luteal stages, whereas intense immunostaining was found in the endothelial and immune cells (Fig. 1H ) and stromal cells in the trabeculae regions (Fig.  1I) . Moreover, cultured midluteal cells (Fig. 1J ) and cultured endothelial cells (Fig. 1K) exhibited immunostaining for CHAT. Granulosa, theca interna, theca externa, and endothelial cells in the blood vessels exhibited intense immunostaining in the ovulatory follicles (Fig. 1L) , whereas granulosa cells and theca interna cells of atretic follicles were devoid of immunostaining (Fig. 1L, inset) .
CHAT Protein Expression in the Luteal Phase
The CHAT protein appeared at the predicted size of 68 kDa, and only one specific band was detected throughout the estrous cycle. The relative level of CHAT protein did not change throughout the estrous cycle (Fig. 2) .
ACH Concentration in Luteal Tissues and Cultured Luteal Cells
The concentration of ACH in luteal tissues did not change during the luteal phase (Fig. 3A) . The ACH concentration in cultured luteal cells increased with time and cell number (P , 0.05) (Fig. 3B ).
Experiment 1: Effect of ACH on P 4 Production and Luteal Cell Viability
An ACH concentration of 10 À7 M significantly stimulated P 4 production by cultured luteal cells (P , 0.05) (Fig. 4A) . Cell viability significantly increased to more than 130% in the presence of 10 À7 M ACH compared with untreated cells (P , 0.05) (Fig. 5A) . Treatment with TNF/IFNG induced apoptosis, and cell viability sharply decreased to 50%. The addition of ACH attenuated the effect of TNF/IFNG, and cell viability significantly reversed in a dose-dependent manner in comparison with TNF/IFNG-treated cells (P , 0.05) (Fig. 5B ).
Experiment 2: Effect of ACH Receptor Antagonists on ACH-Induced P 4 Production and Luteal Cell Viability
Atropine significantly attenuated the effect of ACH-induced P 4 production in cultured luteal cells (P , 0.05) (Fig. 4B) . Atropine and the combination of both atropine and mecamylamine significantly attenuated the effect of ACH-induced cell viability in cultured luteal cells treated with ACH alone (P , 0.05) (Fig. 5C ) or cells treated with ACH in the presence of TNF/IFNG (P , 0.05) (Fig. 5D ), whereas treatment with mecamylamine alone had no effect. Moreover, TUNEL assay revealed that atropine and the combination of both atropine and mecamylamine significantly increased TUNEL-positive cells in cultured luteal cells treated with ACH or treated with ACH in the presence of TNF/IFNG, whereas treatment with mecamylamine alone had no effect (P , 0.05) (Fig. 6 ).
Experiment 3: Effect of TNF/IFNG on CHAT Expression in Cultured Luteal Cells
Cultured midluteal cells exhibited intense immunostaining in the absence of TNF/IFNG (Fig. 7B) , with no staining observed in the negative control (Fig. 7A) . Few cells exhibited pale immunostaining after TNF/IFNG treatment (Fig. 7C) . CHAT protein was expressed in cultured luteal cells, in which the relative amount of CHAT levels decreased significantly in cultured cells treated with TNF/IFNG compared with the control (P , 0.05) (Fig. 7, D 
and E).
Experiment 4: Effects of NGF, IGF1, and TGFB1 on CHAT Protein Expression in Cultured Luteal Cells
The relative levels of CHAT protein expression in cultured midluteal cells increased significantly when cells were treated with NGF, IGF1, or TGFB1 in comparison with the control (P , 0.05) (Fig. 8A) . The addition of NGF at 100 ng/ml did not attenuate the effect of TNF/IFNG on CHAT protein expression (Fig. 8B) .
DISCUSSION
The present study demonstrated, to our knowledge for the first time, the presence and distribution of CHAT (a prerequisite biosynthetic enzyme of ACH) and ACH in bovine CL and cultured bovine luteal cells. CHAT immunostaining was found in the luteal cells and nonluteal cells, including endothelial cells and stromal cells (trabeculae). Protein expression and immunostaining of CHAT also were evident in cultured midluteal cells. Furthermore, ACH was measurable throughout the luteal phase and in cultured luteal cells. ACH concentration in luteal cells increased in culture over time. The overall findings clearly demonstrate ACH production by bovine luteal cells. These data indicate de novo synthesis and a nonneural source of ACH in the bovine CL. The specificity of the CHAT antibody used in the present study was confirmed previously by its reactivity with cholinergic neural cells and fibers in the bovine tissues [33] . These findings are in agreement with those of previous studies that demonstrated CHAT expression and/or ACH production in endocrine tissues, such as ovarian granulosa cells of healthy follicles in humans, monkeys, and rats [9] [10] [11] ; spermatogenic cells and mature spermatozoa in the rat testis [14] ; and syncytiotrophoblast cells in both human and rat placenta [12, 13] .
Acetylcholine has been demonstrated to be derived mainly from cholinergic nerve fibers, part of the vagus nerve fibers, in the ovary based on histochemical staining of ACH-esterase, which degrades ACH into an active metabolite [34] [35] [36] , whereas other studies using the same staining technique have demonstrated a nonneural source of ACH in the granulosa cells, theca cells, CL, stroma, and endothelial cells in the ovary [37, 38] . Rupture of the ovarian follicle wall occurs during ovulation; nerve fibers may regenerate after ovulation as the CL grows and reaches maturity. Regeneration of cholinergic nerve fibers in wound healing and graft transplantation requires 30-60 days [39, 40] . Because the CL has a very short life span, however, ACH is most unlikely to originate from the nerve fibers in the CL. On the other hand, ACH is degraded into inactive metabolites, choline and acetate, by two enzymes. ACH-esterase is located in neurons and nerve fibers, whereas butyrylcholinesterase has been found to be abundant in the plasma and most of the body tissues [41] . The bovine CL has been shown to contain butyrylcholinesterase more than the CL of other species [42] . These data support our current findings of a nonneural source of ACH. Several attempts to amplify CHAT mRNA by PCR failed to detect CHAT transcript in the bovine luteal tissue. Similar findings were reported in several nonneural ACH-producing cells, such as ovarian granulosa cells [9] and urothelium [17] . This may be attributed to unknown splice variants of CHAT [9, 17] . Our ongoing experiments with the dopaminergic and noradrenergic innervation system revealed a nonneural source of dopamine and noradrenaline in the CL (M.O. Al-zi 0 abi and K. Okuda, unpublished data). In the present study, we therefore attempted to clarify the source of ACH in the CL to explain the physiological significance of ACH in the CL.
Cultured luteal endothelial cells and endothelial cells in tissue sections showed intense immunostaining of CHAT. Positive immunostaining of CHAT in the endothelial cells has been shown in both human and rat placenta [13, 14] . Moreover, ACH synthesis and release have been demonstrated in cultured endothelial cells of bovine arteries [43] and human umbilical vein [20] . ACH synthesized by endothelial cells may play a role in the local regulatory loop in vascular tissue [20] . Our data also revealed that nonluteal cells with morphology similar to that of immune cells exhibited intense immunostaining during the late and regressed stages. Several lines of evidence indicated that immune cells, particularly T cells, in the peripheral blood, spleen, and thymus synthesize and secrete ACH and express CHRMs and CHRNs [16, 18, 19] . Immune cells, including lymphocytes, have been shown to increase in numbers during luteolysis in bovine CL [44] . It is possible that ACH regulates immune cell functions in the CL; further study is needed to clarify this assumption. On the other hand, fibrocytes, which are the major cellular compartments of the trabeculae regions and adventitial layers of blood vessels in the CL, exhibited very intense immunostaining throughout the luteal stages. These findings are in agreement with those of previous studies that showed CHAT immunoreactivity in fibrocytes in the placenta [13, 14] and in the adventitial layers surrounding the monkey pulmonary blood vessels [45] . ACH is an unstable molecule that is rapidly degraded by ACH-esterase or butyrylcholinesterase [41] . Therefore, ACH produced in the adventitial layers surrounding the blood vessels in the CL may act locally, such as on the smooth muscles to control blood flow. In fact, CHRMs have been demonstrated in the smooth muscles of the bladder and gastrointestinal tract [46] .
The majority of the luteal cells showed no immunostaining to CHAT during the late and regressed luteal stages, whereas Western blot data showed no significant change throughout the luteal phase. To establish whether CHAT expression in the luteal cells is downregulated during luteal regression, we used our in vitro model to induced apoptosis by TNF/IFNG [47] . 
SOURCE AND ROLE OF ACETYLCHOLINE IN THE CL
Interestingly, TNF/IFNG treatment induced significant decrease in CHAT protein expression and immunostaining density, confirming our immunostaining data in the luteal tissue. These findings strongly suggest a survival role of ACH in the bovine CL by preventing apoptotic cell death during the developing and mid stages, and they lead us to hypothesize that ACH possesses antiapoptotic function in the CL. Our data revealed that ACH protected cultured luteal cells from apoptosis induced by TNF/IFNG. These findings are in agreement with those of several reports that showed a protective role of ACH in various cell types [48] [49] [50] . In the present study, a dose-dependent test with ACH regarding P 4 production by cultured luteal cells showed that a concentration of 10 À7 M has a significant effect, whereas cell viability was significantly increased by ACH at the concentrations of 5 3 10 À8 to 8 3 10 À5 M. The concentration of ACH in human and rat blood plasma has been demonstrated to be approximately 3 3 10 À6 M [51] . Based on the above findings, the concentration used in the present in vitro study seems to be in a physiological range. Because P 4 production was stimulated by ACH, the antiapoptotic effect of ACH in the luteal cell culture may be caused, in part, by increased P 4 production. Because the effective doses of ACH in terms of P 4 production versus cell viability were inconsistent, however, ACH may affect cell viability not only via P 4 stimulated by 10 À7 M ACH but also via other factors stimulated by ACH at concentrations of 5 3 10 À8 M to 8 3 10 À5 M. Actually, our data showed that the cell viability of ACH-treated cells is greater than that of untreated cells. This may be because the luteal steroidogenic cells die spontaneously in the untreated control in our culture system and because ACH maintains the number of viable cells by preventing the spontaneous cell death. ACH also has been demonstrated to possess proliferation activity in various cell types, such as epithelial cells, thymocytes, or glial cells [16] as well as human granulosa cells [8] . Because luteal cells do not show proliferation activity [1] , however, and because ACH stimulates the production of P 4 and oxytocin in cultured bovine luteinized granulosa cells [3] , we postulate that ACH acts as a signal molecule in the luteal cells, controlling the basic cellular processes, such as cell differentiation.
Atropine and the combination of both atropine and mecamylamine significantly attenuated the effect of ACHinduced cell viability in cultured luteal cells treated with ACH alone or with ACH in the presence of TNF/IFNG. The combination effect of both atropine and mecamylamine on the antiapoptotic function of ACH can be attributed to atropine, because treatment with mecamylamine alone showed no effect. These findings clearly indicate that the antiapoptotic function of ACH in the CL is mediated via CHRMs. Several lines of evidence have demonstrated the involvement of CHRMs in preventing apoptosis [52] . Considering that ACH increases the production of P 4 through CHRMs in luteinized granulosa cells [3] and that P 4 possesses antiapoptotic function in bovine CL [53] , ACH may indirectly prevent apoptosis in cultured luteal cells by increasing P 4 production mediated via muscarine receptors. ACH prevents apoptosis in various cell types through its antioxidant action [48] ; the activation of survival signals, such as Ca þ signaling, protein kinase C, mitogenactivated protein kinase phosphorylation, and DNA synthesis [49] ; and protection from mitochondrial impairment and regulation of BCL2 and CASP3 expressions [50] .
Various types of growth factors are expressed in the bovine CL and are believed to regulate CL function directly or indirectly by synergistic or antagonistic mechanisms [54] . We hypothesized, therefore, that locally synthesized ACH in the luteal cells is regulated by growth factors. In the present study, NGF, IGF1, and TGFB1 were selected because of their wellknown effects on CHAT expression and activity in neurons. Our data showed an increase of CHAT expression in cultured luteal cells after treatment with growth factors and NGF did not prevent the effect of TNF/IFNG on CHAT expression. These findings are in agreement with those of previous studies that demonstrated CHAT increasing the activity or expression in neural cells in response to NGF [22, 24, 55] , TGFB1 [56] , and IGF1 [22] . The upregulation of CHAT by locally produced tropic factors support the notion of intraluteal regulation of the CL function [54] .
In conclusion, the expression of CHAT in nonneural tissue (luteal, endothelial, and stromal cells) and ACH detection in CL tissue throughout the luteal phase indicate de novo synthesis of ACH in the bovine CL. Moreover, ACH plays an antiapoptotic role in cultured luteal cells mediated by CHRMs, and the locally synthesized ACH appears to be regulated by NGF, IGF1, and TGFB1 in the bovine CL. The overall findings strongly suggest that locally produced ACH plays an important role in maintaining CL function.
